Cardiology
>
Prevention
—
Recent developments of interest in cardiovascular medicine
by
Nicole Lou, Senior Staff Writer, MedPage Today
September 10, 2024
Not all defibrillator pad positions may work equally well for patients with shockable out-of-hospital cardiac arrest. (JAMA Network Open)
Medical therapy for aortic stenosis? Early clinical data on evogliptin were disappointing but pointed to possible suppression of aortic valve calcification. (Journal of the American College of Cardiology)
Osteoporosis treatments alendronic acid (Fosamax) and denosumab (Prolia) did not help with coronary or aortic calcification. (Journal of the American Heart Association)
Focal pulsed field ablation shows promise for premature ventricular contraction ablation, based on a small observational study. (Circulation: Arrhythmia and Electrophysiology)
With the goal of minimizing the complications associated with transvenous leads in patients with cardiac implantable electronic devices, one center found that tunneling the lead from the contralateral vasculature to the ipsilateral generator was safe and effective. (HeartRhythm)
In England, socioeconomic gaps were apparent when looking at access to heart surgery and survival after a procedure. (Heart)
Study shows the variations in MI care across U.S. Asian ethnic groups. (Circulation: Cardiovascular Quality and Outcomes)
In acute MI-cardiogenic shock, there was no association between annual percutaneous coronary intervention volume and hospital readmissions. (JACC: Heart Failure)
Has research been wrong about the timing of cardiomyocyte troponin release after MI? (Circulation)
Mom’s pre-existing cardiovascular disease during pregnancy was linked to her children’s increased risk of developing the same during childhood and young adulthood. (European Heart Journal)
Regardless of their results on the 6-minute walk test, heart failure patients who experienced post-test shortness of breath had higher odds of mortality in 2 years. (European Journal of Preventive Cardiology)
For people with symptomatic obstructive hypertrophic cardiomyopathy, aficamten had its exercise capacity benefits backed by various secondary assessments in the SEQUOIA-HCM trial. (JAMA Cardiology)
Most people with COVID-19 vaccine-associated myocarditis had some imaging evidence of myocardial injury at approximately the 6-month mark. (eClinicalMedicine)
Former film producer Harvey Weinstein is recovering after having been taken briefly from prison to Bellevue Hospital for an unspecified heart surgery. (Hollywood Reporter)
Nicole Lou is a reporter for MedPage Today, where she covers cardiology news and other developments in medicine. Follow
Information contained on this page is provided by an independent third-party content provider. This website makes no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact editor @pleasantgrove.business
